Clinical Trial Update: Genetic Predisposition Testing Program for Pancreatic Neuroendocrine Neoplasms

View source ↗

Summary

The trial is currently recruiting to evaluate a genetic predisposition testing program in patients with pancreatic neuroendocrine tumor.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Neuroendocrine Tumor

Snippet

Sponsor: University of California, San Francisco | Conditions: Pancreatic Neuroendocrine Neoplasm | Status: RECRUITING